Hey investors, how does the Pacific Northwest stack up in life sciences? It’s a loaded question, given that venture capitalists invested far less in the Pacific Northwest in 2018 than… Read More
Despite some knock-out successes and world-class research, Seattle’s biotechnology industry has remained relatively small compared to other hubs around the country. One of the biggest challenges for the region is… Read More
Silverback Therapeutics, a stealthy biotech startup co-founded by investor, entrepreneur and University of Washington neurosurgery professor Peter Thompson, has raised $10 million in venture funding, according to a filing with the… Read More